drugset / Trial / NCT06961643
Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepatic Function
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The study is being conducted to compare the pharmacokinetics and safety of HRS-7535 in subjects with mild to moderate hepatic impairment and normal hepatic function.
Timeline
- Start
- 2025-06-05
- Primary completion
- 2026-01-22
- Completion
- 2026-01-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-7535 | Small molecule | — | Oral |